FindTrial
Sign In

In pregnancies complicated with pre eclampsia there are various haemostatic parameters that are altered as compared to those patients whose bloodpressure readings are normal, so those parameters can be identified and pregnancies complicated with pre eclampsia can be managed before hand.

Assessment of various parameters of haemostatic assay amongst pre- eclamptic and normotensive pregnancies-A comparative study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/03/032267
Enrollment
108
Registered
2021-03-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O149- Unspecified pre-eclampsia

Interventions

Intervention1: Assessment of various parameters of haemostatic assay amongst pre- eclamptic and normotensive pregnancies-A comparative study: A prospective case control study will be conducted in the

Sponsors

DrArchana Suneja
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Gestational age 24 weeks to 40 weeks pregnancy with singleton live foetus No previous history of hypertension or pre eclampsia or eclampsia

Exclusion criteria

Exclusion criteria: Those women with 1.Hydatidiform Mole 2.Multifoetal Pregnancy 3.Intrauterine Foetal Demise 4.Diabetes Mellitus(Gestational or Overt) Other Medical Conditions: 1.Essential Hypertension/Chronic 2.hypertension 3.Chronic Kidney Disease, 4.Cardiac Disorders 5.Connective Tissue Disease, 6.Autoimmune Disorders 7.Tuberculosis

Design outcomes

Primary

MeasureTime frame
To assess if there are alterations in the various parameters of haemostatic assay in pre-eclamptic women as compared to normotensive pregnancies and to determine if these parameters are useful in the prediction of the severity of pre-eclampsia.Timepoint: 24 to 40 weeks—

Secondary

MeasureTime frame
1.To evaluate the development of pre eclampsia in previously normotensive pregnant women. 2.To assess the progression of mild pre eclamptic patients to severe pre eclampsia. 3.To evaluate if there are significant alterations in parameters of haemostatic assay in mild as compared to severe pre eclampsia Timepoint: 24 to 40 weeks—

Countries

India

Contacts

Public ContactDr Archana Suneja

Bhagat Phool Singh Government Medical College for Women

sunejaarchana1990@gmail.com9767950467

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026